Scott Dunseth Myers - Nov 27, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Nov 27, 2023
Transactions value $
$0
Form type
4
Date filed
11/28/2023, 04:26 PM
Previous filing
Nov 15, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HARP Common Stock Award $0 +5K +32.01% $0.00 20.6K Nov 27, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 25% of the RSUs will vest on each May 27th and November 27th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.